 |
|
July 7, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
|
BIG4BIO
CEO WEEKLY Q&A:
Jehee Suh, CEO, Inocras |
| In this
Q&A, Suh discusses what drew him to
Inocras, why whole-genome analysis is
approaching an inflection point, how
Inocras is building the evidence base for
broader clinical adoption, and what it
will take for whole-genome-based care to
become the new standard in oncology and
rare disease. More |
|
|
- Axsome Therapeutics: Initiates FOCUS-2 Phase
3 Trial of Solriamfetol in Children With
Attention Deficit Hyperactivity Disorder
(ADHD) More
- Biocytogen and Whitehawk
Therapeutics: Enter Global Collaboration for
Bispecific Antibody ADC Development More
- Compass Pathways: Six-Month Data From Second
Phase 3 Trial Confirming Rapid and Durable
Profile More
- LinusBio: Launches Traced, the First
Consumer Wellness Test to Track Environmental
Exposures Over Time More
- Montefiore Einstein: Investigators
Demonstrate How a New Setting for a Digital
Monitoring Device Can Transform Diabetes Care
More
|
|
- Biopharma IPO Fundraising and Returns Soar
in Q2
More*
- Definium Therapeutics: New Employee
Inducement Grants More
- Neurogene: Inducement Grants Under Nasdaq
Listing Rule 5635(c)(4) More
- Nuvation Bio: Full Exercise of Greenshoe
Option in $287.5 Million Convertible Senior
Notes Offering More
- OS Therapies: Third Quarter 2026 Corporate
Outlook More
|
|
- A Decade on the Map: How Big4Bio’s
Regions Moved in GEN’s Top 10 Biopharma
Clusters, 2016–2026
More
- Big4Bio CEO Weekly Q&A: Jehee
Suh, CEO, Inocras More
- BoB@BIO: Biotech Investing and Deals With
Sofinnova's Maha Radhakrishnan, M.D. Podcast
- Bristol Myers Details Krazati
Confirmatory Study Failure in Colorectal
Cancer More*
More*
- Pfizer's Growth Story Faces a Wait as
Pipeline and Leadership Doubts Mount More
- Subscribe to LifeSci Startup for
Updates on US Startups More
|
|
- Feinstein Institutes for Medical Research:
Renowned Physician-Scientist Brian S. Kim
Joins Northwell as First Chief Biotechnology
Officer More
More
- Fierce Biotech Layoff Tracker 2026: BioCryst
Ends Internal Programs; Biogen Sheds Apellis
R&D Roles More
- ICYMI: A View From the Trenches - Biotech
Series A in 2026 More
- OPPORTUNITY: Chief Executive Officer,
Cambridge, MA
More
- OPPORTUNITY: Chief Financial Officer, Pine
Brook, NJ / Hybrid
More
- OPPORTUNITY: Vice President, Global BD,
Remote
More
- Slone Partners: How to De-Risk
Executive Hiring Decisions in Life Sciences
and Healthcare
More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: NYC Life Science Company
Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:NYC,
all rights reserved 2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
